1
|
Sharma S, Tiwari S. RETRACTED: A review on biomacromolecular hydrogel classification and its applications. Int J Biol Macromol 2020; 162:737-747. [PMID: 32553961 DOI: 10.1016/j.ijbiomac.2020.06.110] [Citation(s) in RCA: 101] [Impact Index Per Article: 25.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2020] [Revised: 06/10/2020] [Accepted: 06/11/2020] [Indexed: 12/13/2022]
Abstract
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editor-in-Chief and Author. The work included substantial parts copied without attribution from a prior work by Varaprasad et al (2017): https://doi.org/10.1016/j.msec.2017.05.096
Collapse
Affiliation(s)
- Swati Sharma
- Department of Chemistry, Institute of Science, Banaras Hindu University, Varanasi 221005, (UP), India.
| | - Shachi Tiwari
- Department of Chemistry, Institute of Science, Banaras Hindu University, Varanasi 221005, (UP), India
| |
Collapse
|
2
|
Zakeri M, Mobedi H, Barzin J, Jamshidi A, Mashak A. Development of chitosan beads for controlled release of dexamethasone prepared by co-axial needle method. JOURNAL OF POLYMER RESEARCH 2020. [DOI: 10.1007/s10965-020-02232-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
3
|
El-Hady SM, AbouGhaly MH, El-Ashmoony MM, Helmy HS, El-Gazayerly ON. Colon targeting of celecoxib nanomixed micelles using pulsatile drug delivery systems for the prevention of inflammatory bowel disease. Int J Pharm 2020; 576:118982. [DOI: 10.1016/j.ijpharm.2019.118982] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2019] [Revised: 12/01/2019] [Accepted: 12/17/2019] [Indexed: 01/02/2023]
|
4
|
Ahsan SM, Thomas M, Reddy KK, Sooraparaju SG, Asthana A, Bhatnagar I. Chitosan as biomaterial in drug delivery and tissue engineering. Int J Biol Macromol 2018; 110:97-109. [DOI: 10.1016/j.ijbiomac.2017.08.140] [Citation(s) in RCA: 302] [Impact Index Per Article: 50.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2017] [Revised: 08/16/2017] [Accepted: 08/27/2017] [Indexed: 12/30/2022]
|
5
|
Esim O, Savaser A, Ozkan C, Bayrak Z, Tas C, Ozkan Y. Effect of polymer type on characteristics of buccal tablets using factorial design. Saudi Pharm J 2018; 26:53-63. [PMID: 29379333 PMCID: PMC5783814 DOI: 10.1016/j.jsps.2017.10.013] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2016] [Accepted: 10/24/2017] [Indexed: 11/22/2022] Open
Abstract
A two factor three level factorial design was used to investigate the effects of carbopol and cationic hydrophilic polymers which have a common use in buccal drug formulations. Statistical models with interaction terms were derived to evaluate influence of carbopol (X1) and chitosan (X2) on tablet disintegration (Y1) and dissolution (Y2), mechanical properties (Y3), swelling (Y4). Tablet disintegration studies were carried out using two different pH environments within buccal region pH limits and also two different commonly used dissolution methods for buccal tablets were also investigated to compare the effect of polymer type on dissolution. Polymer type and ratio affect the characteristics of the buccal tablets due to their different physicochemical behavior at buccal pH. Also significant variances between dissolution profiles for buccal tablets, using either USP Paddle or flow through cell methods were found. These results indicate that both polymer type and ratio as well as combination of them effects the drug behavior in different ways.
Collapse
Affiliation(s)
- O. Esim
- University of Health Sciences, Gulhane Campus, Department of Pharmaceutical Sciences, Etlik, Ankara, Turkey
| | - A. Savaser
- University of Health Sciences, Gulhane Campus, Department of Pharmaceutical Sciences, Etlik, Ankara, Turkey
| | - C.K. Ozkan
- University of Health Sciences, Gulhane Campus, Department of Pharmaceutical Sciences, Etlik, Ankara, Turkey
| | - Z. Bayrak
- Ministry of National Defense, Ankara, Turkey
| | - C. Tas
- University of Health Sciences, Gulhane Campus, Department of Pharmaceutical Sciences, Etlik, Ankara, Turkey
| | - Y. Ozkan
- University of Health Sciences, Gulhane Campus, Department of Pharmaceutical Sciences, Etlik, Ankara, Turkey
| |
Collapse
|
6
|
Ong TH, Chitra E, Ramamurthy S, Siddalingam RP, Yuen KH, Ambu SP, Davamani F. Chitosan-propolis nanoparticle formulation demonstrates anti-bacterial activity against Enterococcus faecalis biofilms. PLoS One 2017; 12:e0174888. [PMID: 28362873 PMCID: PMC5376299 DOI: 10.1371/journal.pone.0174888] [Citation(s) in RCA: 43] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2016] [Accepted: 03/16/2017] [Indexed: 11/19/2022] Open
Abstract
Propolis obtained from bee hives is a natural substance with antimicrobial properties. It is limited by its insolubility in aqueous solutions; hence ethanol and ethyl acetate extracts of Malaysian propolis were prepared. Both the extracts displayed antimicrobial and anti-biofilm properties against Enterococcus faecalis, a common bacterium associated with hospital-acquired infections. High performance liquid chromatography (HPLC) analysis of propolis revealed the presence of flavonoids like kaempferol and pinocembrin. This study investigated the role of propolis developed into nanoparticles with chitosan for its antimicrobial and anti-biofilm properties against E. faecalis. Bacteria that grow in a slimy layer of biofilm are resistant to penetration by antibacterial agents. The use of nanoparticles in medicine has received attention recently due to better bioavailability, enhanced penetrative capacity and improved efficacy. A chitosan-propolis nanoformulation was chosen based on ideal physicochemical properties such as particle size, zeta potential, polydispersity index, encapsulation efficiency and the rate of release of the active ingredients. This formulation inhibited E. faecalis biofilm formation and reduced the number of bacteria in the biofilm by ~90% at 200 μg/ml concentration. When tested on pre-formed biofilms, the formulation reduced bacterial number in the biofilm by ~40% and ~75% at 200 and 300 μg/ml, respectively. The formulation not only reduced bacterial numbers, but also physically disrupted the biofilm structure as observed by scanning electron microscopy. Treatment of biofilms with chitosan-propolis nanoparticles altered the expression of biofilm-associated genes in E. faecalis. The results of this study revealed that chitosan-propolis nanoformulation can be deemed as a potential anti-biofilm agent in resisting infections involving biofilm formation like chronic wounds and surgical site infections.
Collapse
Affiliation(s)
- Teik Hwa Ong
- School of Postgraduate Studies, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia
| | - Ebenezer Chitra
- Division of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia
| | - Srinivasan Ramamurthy
- Division of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia
| | | | - Kah Hay Yuen
- School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Penang, Malaysia
| | - Stephen Periathamby Ambu
- Division of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia
| | - Fabian Davamani
- Division of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia
- * E-mail:
| |
Collapse
|
7
|
Tartrate/tripolyphosphate as co-crosslinker for water soluble chitosan used in protein antigens encapsulation. Int J Biol Macromol 2016; 91:381-93. [PMID: 27246374 DOI: 10.1016/j.ijbiomac.2016.05.099] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2015] [Revised: 05/25/2016] [Accepted: 05/28/2016] [Indexed: 10/21/2022]
Abstract
In drug delivery research, several toxic chemical crosslinkers and non-toxic ionic crosslinkers have been exploited for the synthesis of microparticles from acetic acid soluble chitosan. This paper hypothesized the implementation of sodium potassium tartrate (SPT) as an alternative crosslinker for sodium tripolyphosphate (TPP) and SPT/TPP co-crosslinkers for synthesis of the microparticles using water soluble chitosan (WSC) for encapsulation of Bovine serum albumin (BSA) as a model protein, and Tetanus toxoid (TT) as a model vaccine. The crosslinking was confirmed by FT-IR, SEM with EDS. The XRD entailed molecular dispersion of proteins and thermal analysis confirmed the higher stability of STP/TPP co-crosslinked formulations. The resultant microparticles were exhibiting crosslinking degree (52-67%), entrapment efficiency (72-80%), particle size (0.3-1.7μm), zeta potential (+24 to 46mV) and mucoadhesion (41-68%). The superiority of SPT over TPP was confirmed by higher crosslinking degree and entrapment efficiency. However, co-crosslinking were advantageous in higher regression values for Langmuir adsorption isotherm, slower swelling tendency and extended 30days controlled in-vitro release study. TT release obeyed the Quasi-Fickian diffusion mechanism for single and cocrosslinked formulations. Overall, in crosslinking of chitosan as biological macromolecules, STP/TPP may be alternative for single ionic crosslinked formulations for protein antigen delivery.
Collapse
|
8
|
Li Y, Ai L, Yokoyama W, Shoemaker CF, Wei D, Ma J, Zhong F. Properties of chitosan-microencapsulated orange oil prepared by spray-drying and its stability to detergents. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2013; 61:3311-3319. [PMID: 23473289 DOI: 10.1021/jf305074q] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Fragrance encapsulated in small particles of <20 μm diameter is preferred for use in textiles. This study demonstrated that the proper combination of surfactants could produce small and heat-stable emulsion droplets with chitosan that could be spray-dried to produce microcapsules. The microcapsules were able to be deposited onto cotton using water or detergents. It was found that stable emulsion was obtained when Tween 40 and Span 20 were used as compound emulsifiers with the ratio of 4:1 (w/w). The optimum conditions were 1% (w/w) chitosan in acetic acid with the compound emulsifiers of 3-7% (w/w) in the oil, and the inlet temperature for spray-drying was 150 °C. The encapsulation efficiency for orange oil was >90% with a 1:2 (w/w) ratio of oil to chitosan. Microcapsules had a mean diameter of <20 μm and regular particle morphology. The orange oil in the microcapsules was well retained in cotton fabrics after washing in normal detergent solution. The process and products are low in cost, nontoxic, biocompatible, and biodegradable.
Collapse
Affiliation(s)
- Yue Li
- State Key Laboratory of Dairy Biotechnology, Technology Center of Bright Dairy and Food Company Ltd., Shanghai, People's Republic of China
| | | | | | | | | | | | | |
Collapse
|
9
|
Viyoch J, Sudedmark T, Srema W, Suwongkrua W. Development of hydrogel patch for controlled release of alpha-hydroxy acid contained in tamarind fruit pulp extract. Int J Cosmet Sci 2012; 27:89-99. [PMID: 18492158 DOI: 10.1111/j.1467-2494.2004.00250.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Synopsis The aim of this study was to develop hydrogel patch using crosslinked chitosan-starch as polymeric matrix for controlling the release of the natural alpha-hydroxy acid (AHA) contained in the extract of tamarind's fruit pulp. The chitosan (MW 100 000) was blended with corn, tapioca or rice starch in various ratios and then crosslinked with glutaraldehyde. The physical characteristics, mechanical resistance, bio-adhesion property and surface morphology of the prepared hydrogel patches with and without the extract were investigated. The release patterns of the hydrogel patches containing the extract were investigated by measuring the amount of tartaric acid, a major AHA present in the tamarind's fruit pulp extract, accumulated in the receptor medium of the vertical diffusion cell at various time intervals over a period of 6 h. The results indicated that the formulations of chitosan : corn starch 4.5 : 0.5 with glutaraldehyde 0.02% w/w (C(4.5)C(0.5)G(0.02)) or 0.04% w/w (C(4.5)C(0.5)G(0.04)), chitosan : tapioca starch 4.5 : 0.5 with glutaraldehyde 0.04% w/w (C(4.5)T(0.5)G(0.04)) or 0.05% w/w (C(4.5)T(0.5)G(0.05)), and chitosan : rice starch 4.5 : 0.5 with glutaraldehyde 0.04% w/w (C(4.5)R(0.5)G(0.04)) and chitosan : rice starch 4.0 : 1.0 with glutaraldehyde 0.03% w/w (C(4.0)R(1.0)G(0.03)) provided the flexible and elastic patches with good bio-adhesive property. The tensile strength values ranged from 5 to15 N mm(-2) and the elasticity ranged from 30 to 60%. The addition of the extract in these formulations significantly increased the tensile strength values of the obtained patches. The patch of C(4.0)R(1.0)G(0.03) formulation containing the extract showed relatively highest porosity, corresponding to its highest amount (12.02 +/- 0.33 mg) and rate (0.452 +/- 0.012 mg mm(-2) min(-1/2)) of tartaric acid released. The amounts of tartaric acid released from the developed hydrogel patches were proportional to a square root of time (Higuchi's model), particularly the release from C(4.0)R(1.0)G(0.03) (R(2), 0.9978 +/- 0.0020) and C(4.5)R(0.5)G(0.04) (R(2), 0.9961 +/- 0.0024) patches.
Collapse
Affiliation(s)
- J Viyoch
- Department of Pharmaceutical Technology, Naresuan University, Phitsanulok, Thailand.
| | | | | | | |
Collapse
|
10
|
Mishra RK, Ramasamy K, Ban NN, Majeed ABA. Synthesis of poly[3-(methacryloylamino) propyl trimethylammonium chloride-co-methacrylic acid] copolymer hydrogels for controlled indomethacin delivery. J Appl Polym Sci 2012. [DOI: 10.1002/app.38491] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
11
|
S. Pendekal M, K. Tegginamat P. Formulation and evaluation of a bioadhesive patch for buccal delivery of tizanidine. Acta Pharm Sin B 2012. [DOI: 10.1016/j.apsb.2011.12.012] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
12
|
Gulbake A, Jain SK. Chitosan: a potential polymer for colon-specific drug delivery system. Expert Opin Drug Deliv 2012; 9:713-29. [DOI: 10.1517/17425247.2012.682148] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
13
|
Yasufuku T, Anraku M, Kondo Y, Hata T, Hirose J, Kobayashi N, Tomida H. Useful Extend-release Chitosan Tablets with High Antioxidant Activity. Pharmaceutics 2010; 2:245-257. [PMID: 27721354 PMCID: PMC3986719 DOI: 10.3390/pharmaceutics2020245] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2010] [Revised: 05/21/2010] [Accepted: 05/26/2010] [Indexed: 11/22/2022] Open
Abstract
The antioxidant properties of different low molecular weight (LMW) chitosans (CS1; 22 kDa, CS2; 38 kDa, CS3; 52 kDa, CS4; 81 kDa) were examined for possible use in extended-release tablets. The criteria used were the ability of the chitosans to reduce Cu2+, and hydroxyl and superoxide radicals and N-centered radicals derived from 1,1'-diphenyl-2-picrylhydrazyl, via the use of ESR spectrometry. CS2 showed the highest scavenging activity. CS1 and CS3, however, were much less effective and CS4 was not a viable antioxidant. The results suggest that CS2 could be useful in combating the development of oxidative stress. A series of chitosan tablets were prepared using a spray drying method and evaluated as an extended-release matrix tablet using theophylline (TPH) as a model drug. The release of TPH from the different MW chitosan tablets increased with increasing MW of the chitosan used. CS2, CS3 and CS4 showed a reasonable release activity, but CS1 showed the shortest release activity. Moreover, the CS2-TPH tablet showed the highest scavenging activity of the three chitosan tablets (CS2-CS4) using 2,2'-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) radicals. These results suggest that a CS2-TPH tablet could be potentially useful in an extended-release matrix tablet with a high antioxidant activity.
Collapse
Affiliation(s)
- Taira Yasufuku
- Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 1 Sanzo, Gakuen-cho, Fukuyama 729-0292, Japan
| | - Makoto Anraku
- Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 1 Sanzo, Gakuen-cho, Fukuyama 729-0292, Japan
| | - Yuko Kondo
- Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 1 Sanzo, Gakuen-cho, Fukuyama 729-0292, Japan
| | - Toshiyuki Hata
- Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 1 Sanzo, Gakuen-cho, Fukuyama 729-0292, Japan
| | - Junzo Hirose
- Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 1 Sanzo, Gakuen-cho, Fukuyama 729-0292, Japan
| | - Nobuyuki Kobayashi
- Dainichiseika Color & Chemicals Mfg. Co., Ltd., 7-6, Nihonbashi Bakuro-cho 1-chome, Chuo-ku, Tokyo, 103-8383, Japan
| | - Hisao Tomida
- Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 1 Sanzo, Gakuen-cho, Fukuyama 729-0292, Japan.
| |
Collapse
|
14
|
Munasur AP, Pillay V, Choonara YE, Mackraj I, Govender T. Comparing the Mucoadhesivity and Drug Release Mechanisms of Various Polymer-Containing Propranolol Buccal Tablets. Drug Dev Ind Pharm 2009; 34:189-98. [DOI: 10.1080/03639040701539842] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
15
|
Amrutkar JR, Gattani SG. Chitosan-chondroitin sulfate based matrix tablets for colon specific delivery of indomethacin. AAPS PharmSciTech 2009; 10:670-7. [PMID: 19459052 DOI: 10.1208/s12249-009-9253-y] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2009] [Accepted: 04/28/2009] [Indexed: 11/30/2022] Open
Abstract
The different approaches for targeting orally administered drugs to the colon include coating with pH-dependent polymers, design of time-release dosage forms, and the utilization of carriers that are degraded exclusively by colonic bacteria. The aim of the present study was to develop a single unit, site-specific drug formulation allowing targeted drug release in the colon. Matrix tablets were prepared by wet granulation using cross-linked chitosan (ChI) and chondroitin sulfate (ChS) polysaccharides as binder and carrier. ChS was used to form polyelectrolyte complexes (PEC) with ChI, and its potential as a colon-targeted drug carrier was investigated. Indomethacin was used as a model drug. The ChI and ChS PEC was characterized by Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC) and powder X-ray diffraction studies (XRD). The matrix tablets were tested in vitro for their suitability as colon-specific drug delivery systems. FTIR demonstrated that the PEC forms through an electrostatic interaction between the protonated amine (NH(3)(+) group of ChI with the free carboxylate (COO(-)) group and sulfate (SO(4)(2-)) group of ChS. DSC and XRD indicated that the PEC has different thermal characteristics from ChI or ChS. The dissolution data demonstrates that the dissolution rate of the tablet is dependent upon the concentration of polysaccharide used as binder and matrix and time of cross-linking. The study confirmed that selective delivery of indomethacin to the colon can be achieved using cross-linked ChI and ChS polysaccharides.
Collapse
|
16
|
Ballal NV, Kundabala M, Bhat KS, Acharya S, Ballal M, Kumar R, Prakash PY. Susceptibility ofCandida albicansandEnterococcus faecalisto Chitosan, Chlorhexidine gluconate and their combinationin vitro. AUST ENDOD J 2009; 35:29-33. [DOI: 10.1111/j.1747-4477.2008.00126.x] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
17
|
|
18
|
Ritthidej GC, Chomto P, Pummangura S, Menasveta P. Chitin and Chitosan as Disintegrants in Paracetamol Tablets. Drug Dev Ind Pharm 2008. [DOI: 10.3109/03639049409050225] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
19
|
Vázquez MJ, Pérez-Marcos B, Gómez-Amoza J, -Pacheco RIA, Souto C, Concheiro A. Influence of technological variables on release of drugs from hydrophilic matrices. Drug Dev Ind Pharm 2008. [DOI: 10.3109/03639049209046332] [Citation(s) in RCA: 86] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
20
|
Goskonda SR, Upadrashta SM. Avicel RC-591/Chitosan Beads by Extrusion-Spheronization Technology. Drug Dev Ind Pharm 2008. [DOI: 10.3109/03639049309062991] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
21
|
Adusumilli PS, Bolton SM. Evaluation of Chitosan Citrate Complexes as Matrices for Controlled Release Formulations Using a 32full Factorial Design. Drug Dev Ind Pharm 2008. [DOI: 10.3109/03639049109048059] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
22
|
Kristmundsdottir T, Ingvarsdóttir K, Sémundsdóttir G. Chitosan Matrix Tablets: The Influence of Excipients on Drug Release. Drug Dev Ind Pharm 2008. [DOI: 10.3109/03639049509069249] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
23
|
Değim İT, Tuğcu-Demiröz F, Tamer-İlbasmış S, Acartürk F. Development of Controlled Release Sildenafil Formulations for Vaginal Administration. Drug Deliv 2008; 15:259-65. [DOI: 10.1080/10717540802006781] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
24
|
Suedee R, Bodhibukkana C, Tangthong N, Amnuaikit C, Kaewnopparat S, Srichana T. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane. J Control Release 2008; 129:170-8. [DOI: 10.1016/j.jconrel.2008.05.001] [Citation(s) in RCA: 65] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2008] [Revised: 04/29/2008] [Accepted: 05/03/2008] [Indexed: 10/22/2022]
|
25
|
Formulation of monolayered films with drug and polymers of opposing solubilities. Int J Pharm 2008; 358:184-91. [DOI: 10.1016/j.ijpharm.2008.03.005] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2007] [Revised: 01/29/2008] [Accepted: 03/07/2008] [Indexed: 11/18/2022]
|
26
|
Amin M, Abdel-Raheem I, Madkor H. Wound healing and anti-inflammatory activities of bee venom-chitosan blend films. J Drug Deliv Sci Technol 2008. [DOI: 10.1016/s1773-2247(08)50082-7] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
27
|
|
28
|
Liu H, Yang XG, Nie SF, Wei LL, Zhou LL, Liu H, Tang R, Pan WS. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: Screening of formulation variables and in vitro investigation. Int J Pharm 2007; 332:115-24. [PMID: 17052871 DOI: 10.1016/j.ijpharm.2006.09.038] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2006] [Revised: 08/14/2006] [Accepted: 09/24/2006] [Indexed: 10/24/2022]
Abstract
A microbially triggered colon-targeted osmotic pump (MTCT-OP) has been studied. The gelable property at acid condition and colon-specific biodegradation of chitosan were used to: (1) produce the osmotic pressure, (2) form the drug suspension and (3) form the in situ delivery pores for colon-specific drug release, respectively. The scanning electron microscopy (SEM) study and the calculation of membrane permeability were applied to elucidate the mechanism of MTCT-OP. The effects of different formulation variables, including the level of pH-regulating excipient (citric acid) and the amount of chitosan in the core, the weight gain of semipermeable membrane and enteric-coating membrane, and the level of pore former (chitosan) in the semipermeable membrane, have been studied. Results of SEM showed that the in situ delivery pores could be formed in predetermined time after coming into contact with dissolution medium, and the number of pore was dependent on the initial level of pore former in the membrane. The amount of budesonide release was directly proportional to the initial level of pore former, but inversely related to the weight of semipermeable membrane. The effects of variations in the level of citric acid and chitosan in the core formulation on drug release were studied. The different levels of enteric-coating membrane could prevent cellulose acetate membrane (containing chitosan as pore former) from forming pore or rupture before contact with simulated colonic fluid, but had no effect on the drug release. Budesonide release from the developed formulation was inversely proportional to the osmotic pressure of the release medium, confirming that osmotic pumping was the major mechanism of drug release. These results showed that MTCT-OP based on osmotic technology and microbially triggered mechanism had a high potential for colon-specific drug delivery.
Collapse
Affiliation(s)
- Hui Liu
- School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, P.O. Box 122, Shenyang 110016, PR China
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Xie Y, Xu B, Gao Y. Controlled transdermal delivery of model drug compounds by MEMS microneedle array. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 2005; 1:184-90. [PMID: 17292077 DOI: 10.1016/j.nano.2005.03.001] [Citation(s) in RCA: 69] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/26/2004] [Accepted: 03/10/2005] [Indexed: 12/01/2022]
Abstract
This article reports an in vitro study of microneedle-array-enhanced transdermal transport of model drug compounds dispersed in chitosan films. Each microneedle array has 400 out-of-plane, needle-shaped microstructures fabricated using micro-electro-mechanical systems (MEMS) technology to ensure adequate mechanical strength and high precision, and consistency. A nanometer coating on the microneedles ensured the biocompatibility that is important in the application of transdermal drug delivery. Model drugs selected to investigate skin permeation in vitro were calcein, a small molecule (molecular weight, 623 d) that has little skin penetration, and bovine serum albumin (BSA) (molecular weight, 66,000 d), a hydrophilic biological macromolecule. A Franz permeation cell was used to characterize the permeation rate of calcein and BSA through the rat skin. The transdermal transport behavior of BSA was investigated from solid films coated on the surface of microneedle arrays with various chitosan concentrations, film thicknesses, and BSA contents. The BSA permeation rate decreased with the increase of the chitosan concentration; the thicker the film, the slower the permeation rate. In addition, the permeation rate increased with the increase of BSA loading dose. A linear relationship existed between the permeation rate and the square root of the BSA loading dose. Results showed that the chitosan hydrophilic polymer film acts as a matrix that can regulate the BSA release rate. The controlled delivery of BSA can be achieved using the BSA-containing chitosan matrix film incorporated with the microneedle arrays. This will provide a possible way for the transdermal delivery of macromolecular therapeutic agents such as proteins and vaccines.
Collapse
Affiliation(s)
- Yu Xie
- Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, China
| | | | | |
Collapse
|
30
|
Nunthanid J, Laungtana-Anan M, Sriamornsak P, Limmatvapirat S, Puttipipatkhachorn S, Lim LY, Khor E. Characterization of chitosan acetate as a binder for sustained release tablets. J Control Release 2005; 99:15-26. [PMID: 15342177 DOI: 10.1016/j.jconrel.2004.06.008] [Citation(s) in RCA: 117] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2003] [Accepted: 06/04/2004] [Indexed: 11/16/2022]
Abstract
A chitosan derivative as an acetate salt was successfully prepared by using a spray drying technique. Physicochemical characteristics and micromeritic properties of spray-dried chitosan acetate (SD-CSA) were studied as well as drug-polymer and excipient-polymer interaction. SD-CSA was spherical agglomerates with rough surface and less than 75 microm in diameter. The salt was an amorphous solid with slight to moderate hygroscopicity. The results of Fourier transform infrared (FTIR) and solid-state (13)C NMR spectroscopy demonstrated the functional groups of an acetate salt in its molecular structure. DSC and TGA thermograms of SD-CSA as well as FTIR and NMR spectrum of the salt, heated at 120 degrees C for 12 h, revealed the evidence of the conversion of chitosan acetate molecular structure to N-acetylglucosamine at higher temperature. No interaction of SD-CSA with either drugs (salicylic acid and theophylline) or selected pharmaceutical excipients were observed in the study using DSC method. As a wet granulation binder, SD-CSA gave theophylline granules with good flowability (according to the value of angle of repose, Carr's index, and Hausner ratio) and an excellent compressibility profile comparable to a pharmaceutical binder, PVP K30. In vitro release study of theophylline from the tablets containing 3% w/w SD-CSA as a binder demonstrated sustained drug release in all media. Cumulative drug released in 0.1 N HCl, pH 6.8 phosphate buffer and distilled water was nearly 100% within 6, 16 and 24 h, respectively. It was suggested that the simple incorporation of spray-dried chitosan acetate as a tablet binder could give rise to controlled drug delivery systems exhibiting sustained drug release.
Collapse
Affiliation(s)
- J Nunthanid
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
| | | | | | | | | | | | | |
Collapse
|
31
|
Savaşer A, Ozkan Y, Işimer A. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium. ACTA ACUST UNITED AC 2005; 60:171-7. [PMID: 15752476 DOI: 10.1016/j.farmac.2004.10.001] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2003] [Accepted: 10/18/2004] [Indexed: 10/26/2022]
Abstract
The effects of formulation variables on the release profile of diclofenac sodium (DS) from hydroxypropylmethyl cellulose (HPMC) and chitosan matrix tablets were studied. DS tablets were prepared by wet granulation and direct compression methods and different ratios of HPMC and chitosan were used. Physical properties of the prepared tablets and targeted commercial sustained release (SR) tablet and the drug release were studied in tablets that were placed in 0.1 M HCl for 1 h and phosphate buffer solution was added to reach pH value of 7.5. In vitro studies showed that 20% HPMC contained SR formulation with direct (dry) compression method is the optimum formulation due to its better targeting profile in terms of release. This formulation also exhibited the best-fitted formulation into the zero order kinetics. The precision and accuracy of the analytical method were also checked. The repeatability and reproducibility of the method were also determined.
Collapse
Affiliation(s)
- Ayhan Savaşer
- Department of Pharmaceutical Technology, Gülhane Military Medical Academy, Etlik, 06018 Ankara, Turkey
| | | | | |
Collapse
|
32
|
Avadi M, Ghassemi A, A.M.M.Sadeghi, Beiki D, Akbarzadeh A, Ebrahimnejad P, Shahhosseini S, Bayati K, Rafiee-Tehrani M. γ-scintigraphic evaluation of enteric-coated capsules containing chitosan-brilliant blue gel beads as hydrophilic model for colon drug delivery. J Drug Deliv Sci Technol 2005. [DOI: 10.1016/s1773-2247(05)50069-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
33
|
Park CR, Munday DL. Evaluation of Selected Polysaccharide Excipients in Buccoadhesive Tablets for Sustained Release of Nicotine. Drug Dev Ind Pharm 2004; 30:609-17. [PMID: 15285334 DOI: 10.1081/ddc-120037492] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Some naturally occurring biocompatible materials were evaluated as mucoadhesive controlled release excipients for buccal drug delivery. A range of tablets were prepared containing 0-50% w/w xanthan gum, karaya gum, guar gum, and glycol chitosan and were tested for swelling, drug release, and mucoadhesion. Guar gum was a poor mucoadhesive and lacked sufficient physical integrity for buccal delivery. Karaya gum demonstrated superior adhesion to guar gum and was able to provide zero-order drug release, but concentrations greater than 50% w/w may be required to provide suitable sustained release. Xanthan gum showed strong adhesion to the mucosal membrane and the 50% w/w formulation produced zero-order drug release over 4 hours, about the normal time interval between daily meals. Glycol chitosan produced the strongest adhesion, but concentrations greater than 50% w/w are required to produce a nonerodible matrix that can control drug release for over 4 hours. Swelling properties of the tablets were found to be a valuable indicator of the ability of the material to produce sustained release. Swelling studies also gave an indication of the adhesion values of the gum material where adhesion was solely dependent upon penetration of the polymer chains into the mucus layer.
Collapse
Affiliation(s)
- Calum R Park
- School of Pharmacy, The Robert Gordon University, Aberdeen, Scotland, UK
| | | |
Collapse
|
34
|
Agrawal AM, Howard MA, Neau SH. Extruded and Spheronized Beads Containing No Microcrystalline Cellulose: Influence of Formulation and Process Variables. Pharm Dev Technol 2004; 9:197-217. [PMID: 15202579 DOI: 10.1081/pdt-120030250] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The purposes of this study were to investigate the use of chitosan in the manufacture of beads by extrusion-spheronization without inclusion of microcrystalline cellulose, and to study the effect of formulation and process variables on the characteristics of the beads. Beads containing chitosan, fine particle ethylcellulose, hydroxypropyl methylcellulose (HPMC), and caffeine as the model drug were manufactured. Bead size, yield, shape, friability, density, porosity, and release studies were determined. Spherical beads with good mechanical properties could be manufactured without microcrystalline cellulose. Release studies showed that there was immediate release of drug from the beads. A five factor, half fraction screening design was employed to study the effect of formulation variables and process variables on the properties of the beads. Statistical analysis indicated that formulation variables such as the chitosan content, HPMC content, and water content, and process variables such as the spheronizer speed and extruder speed significantly affected the physical properties of the beads. The bead size decreased with an increase in chitosan content. Significant two-factor interactions exist between the variables for several of the measured responses. Beads with high percentage yield and high sphericity can be obtained at high chitosan content, and low HPMC content, water content, spheronizer speed, and extruder speed. Less friable beads can be obtained at high levels of studied formulation variables and low levels of studied process variables. Beads of high density and low porosity can be manufactured at high levels of the studied formulation and process variables. Regression equations were generated using Statgraphics Plus software that can be used to develop formulations with desired bead properties. Chitosan was useful to provide beads of acceptable physical properties using water as a granulating fluid in the extrusion-spheronization process.
Collapse
Affiliation(s)
- Anjali M Agrawal
- Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri 64110-2499, USA
| | | | | |
Collapse
|
35
|
Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S. Chitosan microspheres as a potential carrier for drugs. Int J Pharm 2004; 274:1-33. [PMID: 15072779 DOI: 10.1016/j.ijpharm.2003.12.026] [Citation(s) in RCA: 573] [Impact Index Per Article: 28.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2002] [Revised: 12/02/2003] [Accepted: 12/12/2003] [Indexed: 11/30/2022]
Abstract
Chitosan is a biodegradable natural polymer with great potential for pharmaceutical applications due to its biocompatibility, high charge density, non-toxicity and mucoadhesion. It has been shown that it not only improves the dissolution of poorly soluble drugs but also exerts a significant effect on fat metabolism in the body. Gel formation can be obtained by interactions of chitosans with low molecular counterions such as polyphosphates, sulphates and crosslinking with glutaraldehyde. This gelling property of chitosan allows a wide range of applications such as coating of pharmaceuticals and food products, gel entrapment of biochemicals, plant embryo, whole cells, microorganism and algae. This review is an insight into the exploitation of the various properties of chitosan to microencapsulate drugs. Various techniques used for preparing chitosan microspheres and evaluation of these microspheres have also been reviewed. This review also includes the factors that affect the entrapment efficiency and release kinetics of drugs from chitosan microspheres.
Collapse
Affiliation(s)
- V R Sinha
- University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India.
| | | | | | | | | | | | | |
Collapse
|
36
|
|
37
|
Abstract
The aim of the present study was to develop a single unit, site-specific drug formulation allowing targeted drug release in the colon. Tablets were prepared using polysaccharides or synthetic polymer as binders. These included xanthan gum, guar gum, chitosan and Eudragit E. Indomethacin was used as a model drug. The prepared tablets were enteric coated with Eudragit-L 100 to give protection in the stomach. The coated tablets were tested in-vitro for their suitability as colon specific drug delivery systems. The drug release studies were carried out in simulated stomach environment (pH 1.2) for 2 h followed by small intestinal environment at pH 6.8. The dissolution data obtained from tablets demonstrates that the dissolution rate of the tablet is dependent upon the type and concentration of polysaccharide/polymer used as binder. The results demonstrate that enteric coated tablets containing 3% chitosan as a binder, showed only 12.5% drug release in the first 5 h, which is the usual upper gastrointestinal transit time, whereas, tablets prepared using guar gum as binder, were unable to protect drug release under similar conditions. Preparations with xanthan gum as a binder formed time-dependent release formulations. When used in a concentration of 5.92% in the tablets, 28% drug release was observed in the usual upper gastrointestinal tract conditions. It was also found that enteric coated preparation formulated with 8.88% of Eudragit E as binder could be used to carry water insoluble drug molecules to the colon especially in IBD. The above study shows that chitosan could be successfully used as a binder, for colon targeting of water insoluble drugs in preference to guar gum when used in the same concentration. Additionally, formulations developed with chitosan and Eudragit E would be highly site specific since drug release would be at a retarded rate till microbial degradation or polymer solubilization takes place in the colon.
Collapse
Affiliation(s)
- V R Sinha
- University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160 014, India.
| | | |
Collapse
|
38
|
Shi XY, Tan TW. Preparation of chitosan/ethylcellulose complex microcapsule and its application in controlled release of vitamin D2. Biomaterials 2002; 23:4469-73. [PMID: 12322966 DOI: 10.1016/s0142-9612(02)00165-5] [Citation(s) in RCA: 102] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
A system which consists of chitosan (CS) microcores entrapped within enteric polymer is investigated. Vitamin D2 (VD2) used as a model drug, was efficiently entrapped in CS microcores using spray drying and was microencapsulated by coating of ethylcellulose. The morphology and release properties of microcapsules were tested. The factors which influenced the preparation, including molecular weight of CS, concentration of CS solution, concentration of acetic acid and loading of VD2, were discussed. The results of release in vitro showed that the microcapsules could realize sustained release in intestine juice.
Collapse
Affiliation(s)
- Xin-Yuan Shi
- College of Chemical Engineering, Beijing University of Chemical Technology, China
| | | |
Collapse
|
39
|
El-Kamel A, Sokar M, Naggar V, Al Gamal S. Chitosan and sodium alginate-based bioadhesive vaginal tablets. AAPS PHARMSCI 2002; 4:E44. [PMID: 12646014 PMCID: PMC2751333 DOI: 10.1208/ps040444] [Citation(s) in RCA: 67] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Metronidazole was formulated in mucoadhesive vaginal tablets by directly compressing the natural cationic polymer chitosan, loosely cross-linked with glutaraldehyde, together with sodium alginate with or without microcrystalline cellulose (MCC). Sodium carboxymethylcellulose (CMC) was added to some of the formulations. The drug content in tablets was 20%. Drug dissolution rate studies from tablets were carried out in buffer pH 4.8 and distilled water. Swelling indices and adhesion forces were also measured for all formulations. The formula (FIII) containing 6% chitosan, 24% sodium alginate, 30% sodium CMC, and 20% MCC showed adequate release properties in both media and gave lower values of swelling index compared with the other examined formulations. FIII also proved to have good adhesion properties with minimum applied weights. Moreover, its release properties (% dissolution efficiency, DE) in buffer pH 4.8, as well as release mechanism (n values), were negligibly affected by aging. Thus, this formula may be considered a good candidate for vaginal mucoadhesive dosage forms.
Collapse
Affiliation(s)
- Amal El-Kamel
- Department of Pharmaceutics, Faculty of Pharmacy, King Saud University, Kingdom of Saudi Arabia.
| | | | | | | |
Collapse
|
40
|
Santos H, Veiga F, Pina M, Podczeck F, Sousa J. Physical properties of chitosan pellets produced by extrusion–spheronisation: influence of formulation variables. Int J Pharm 2002; 246:153-69. [PMID: 12270618 DOI: 10.1016/s0378-5173(02)00376-9] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Pellets comprising chitosan, cellulose microcrystalline, povidone, filler excipient and diclofenac sodium as model drug were prepared by extrusion-spheronisation. The effects of chitosan load (zero, 0%, low, 4% and high, 16% levels), type of filler (lactose, tribasic calcium phosphate and beta-cyclodextrin) and composition of the binding liquid (ethanol/water mixtures 20 and 50%) on physical characteristics of pellets were evaluated. A three-factor factorial design was employed in the study. Analysis of variance (ANOVA) indicated that single factors had significant effect on the physical characteristics of the pellets. The type of filler followed by polymer load markedly affected the density. The type of binding liquid had negligible effect on the shape and surface roughness of the pellets. Increase in the chitosan load resulted in pellets of lower porosity values. This could be attributed to the binding capacity of chitosan and povidone leading to more compacted structures. Chitosan load and type of filler had significant influence on the surface roughness. The surface of pellets became rougher as the chitosan load increased, however, there was no significant difference between zero and low contents of chitosan. Pellets prepared using tribasic calcium phosphate showed a smoother surface when compared with formulations including lactose or beta-cyclodextrin. Chitosan was useful to provide pellets of acceptable physical characteristics when employing an alcohol/water mixture 50% (v/v) as binding liquid for the extrusion-spheronisation process.
Collapse
Affiliation(s)
- H Santos
- Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Rua do Norte, 3049 Coimbra Codex, Portugal.
| | | | | | | | | |
Collapse
|
41
|
Banerjee T, Mitra S, Kumar Singh A, Kumar Sharma R, Maitra A. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm 2002; 243:93-105. [PMID: 12176298 DOI: 10.1016/s0378-5173(02)00267-3] [Citation(s) in RCA: 297] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Chitosan nanoparticles cross-linked with glutaraldehyde have been prepared in AOT/n hexane reverse micellar system. The cross-linking in the polymeric network has been confirmed from FTIR data. Because of the adhesive nature of these particles, their sizes, as measured by QELS, have been found dependent on the particle density in aqueous buffer. The particle size has also been found to vary with the amount of cross-linking. The actual particle size of these chitosan nanoparticles with a particular degree of cross-linking has been determined at infinite dilution of particles in water. The particle size at infinite dilution is approximately 30 nm diameter, when 10% of the amine groups in the polymeric chains have been cross-linked and it shoots up to 110 nm diameter when all the amine groups are cross-linked (100% cross-linked). TEM pictures show that these particles are spherical in shape and remain in the form of aggregation. The biodistribution of these particles after intravenous injections in mice showed that these particles readily evade the RES system and remain in the blood for a considerable amount of time. The gamma image of the rabbit after administration of (99m)Technetium (99mTc) tagged chitosan nanoparticles also confirms the above observation, as the blood pool is readily visible even after 2 h. The gamma picture shows distribution of particles in the heart, liver, kidneys, bladder and the vertebral column. Interestingly, the biodistribution studies of the chitosan nanoparticles have indicated that these particles are distributed in the bone marrow also, implying the possibility of using these nanoparticles for bone imaging and targeting purpose.
Collapse
Affiliation(s)
- Tanima Banerjee
- Department of Chemistry, University of Delhi, Delhi 110007, India
| | | | | | | | | |
Collapse
|
42
|
Pharmaceutical Polymeric Controlled Drug Delivery Systems. FILLED ELASTOMERS DRUG DELIVERY SYSTEMS 2002. [DOI: 10.1007/3-540-45362-8_2] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
|
43
|
Abstract
Chitosan, a natural polysaccharide, is being widely used as a pharmaceutical excipient. It is obtained by the partial deacetylation of chitin, the second most abundant natural polymer. Chitosan comprises a series of polymers varying in their degree of deacetylation, molecular weight, viscosity, pKa etc. The presence of a number of amino groups permit chitosan to chemically react with anionic systems, thereby resulting in alteration of physicochemical characteristics of such combinations. Chitosan has found wide applicability in conventional pharmaceutical devices as a potential formulation excipient, some of which include binding, disintegrating and tablet coating properties. The polymer has also been investigated as a potential adjuvant for swellable controlled drug delivery systems. Use of chitosan in novel drug delivery as mucoadhesive, gene and peptide drug administration via the oral route as well as its absorption enhancing effects have been explored by a number of researchers. Chitosan exhibits myriad biological actions, namely hypocholesterolemic, antimicrobial and wound healing properties. Low toxicity coupled with wide applicability makes it a promising candidate not only for the purpose of drug delivery for a host of drug moieties (antiinflammatories, peptides etc.) but also as a biologically active agent. It is the endeavour of the present review to provide an insight into the biological and pharmaceutical profile of chitosan. Various investigations carried out recently are reported, although references to research performed on chitosan prior to the recent reviews have also been included, where appropriate.
Collapse
Affiliation(s)
- A K Singla
- Pharmaceutics Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
| | | |
Collapse
|
44
|
GUPTA KAILASHC, RAVI KUMAR MAJETINV. An Overview on Chitin and Chitosan Applications with an Emphasis on Controlled Drug Release Formulations. ACTA ACUST UNITED AC 2000. [DOI: 10.1081/mc-100102399] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
45
|
Bhardwaj TR, Kanwar M, Lal R, Gupta A. Natural gums and modified natural gums as sustained-release carriers. Drug Dev Ind Pharm 2000; 26:1025-38. [PMID: 11028217 DOI: 10.1081/ddc-100100266] [Citation(s) in RCA: 165] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Although natural gums and their derivatives are used widely in pharmaceutical dosage forms, their use as biodegradable polymeric materials to deliver bioactive agents has been hampered by the synthetic materials. These natural polysaccharides do hold advantages over the synthetic polymers, generally because they are nontoxic, less expensive, and freely available. Natural gums can also be modified to have tailor-made materials for drug delivery systems and thus can compete with the synthetic biodegradable excipients available in the market. In this review, recent developments in the area of natural gums and their derivatives as carriers in the sustained release of drugs are explored.
Collapse
Affiliation(s)
- T R Bhardwaj
- University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
| | | | | | | |
Collapse
|
46
|
Phaechamud T, Koizumi T, Ritthidej GC. Chitosan citrate as film former: compatibility with water-soluble anionic dyes and drug dissolution from coated tablet. Int J Pharm 2000; 198:97-111. [PMID: 10722954 DOI: 10.1016/s0378-5173(99)00460-3] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Chitosan citrate solution containing 25% w/w propylene glycol was prepared and tested for its compatibility with some water soluble anionic dyes. The immiscibility between erythrosine, ponceau 4R, sunset yellow or tartrazine solutions and chitosan citrate solution was evident. The Fourier transform-infrared spectra revealed charged interaction between anionic dye and chitosan. Brilliant blue and green FS at concentration of 0.02-1.00% w/w polymer could be miscible with chitosan citrate solution due to the decrease in charge interaction by the positive charge on molecule of brilliant blue, which was also the composition in green FS. Propranolol HCl tablets coated with these colored film-coating solutions exhibited good appearance and no color migration. Drug dissolution from coated tablets was pH dependent, corresponding to the ability of chitosan to protonate in the medium. Color incorporation slightly retarded drug dissolution in acidic medium. Drug dissolved from coated tablet colored with brilliant blue was faster than from that colored with green FS. This was because brilliant blue had positive charge and more SO(3)H groups on its molecular structure, and exhibited higher water solubility. Accelerated condition could alter dissolution characteristics, and the Td+t(0) value from curve fitting between the dissolution profiles and Weibull equation was increased. However, drug dissolution from freshly prepared coated tablets, coated tablets after exposure to accelerated condition and after storage at room temperature for 12 months conformed to the monograph in USP XXIII.
Collapse
Affiliation(s)
- T Phaechamud
- Department of Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
| | | | | |
Collapse
|
47
|
Abstract
The aim of this review is to give an insight into the many potential applications of chitosan as a pharmaceutical drug carrier. The first part of this review concerns the principal uses of chitosan as an excipient in oral formulations (particularly as a direct tableting agent) and as a vehicle for parenteral drug delivery devices. The use of chitosan to manufacture sustained-release systems deliverable by other routes (nasal, ophthalmic, transdermal, and implantable devices) is discussed in the second part.
Collapse
Affiliation(s)
- O Felt
- School of Pharmacy, University of Geneva, Switzerland
| | | | | |
Collapse
|
48
|
el Fattah EA, Grant DJ, Gabr KE, Meshali MM. Physical characteristics and release behavior of salbutamol sulfate beads prepared with different ionic polysaccharides. Drug Dev Ind Pharm 1998; 24:541-7. [PMID: 9876620 DOI: 10.3109/03639049809085655] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Salbutamol sulfate beads were prepared using anionic and cationic polysaccharides, Gelrite and chitosan, respectively. Alginate beads were also prepared for comparison. The mean diameter, porosity, and drug content of the beads were determined. The beads were examined by scanning electron microscopy (SEM), DSC, and x-ray diffraction. The drug release from the beads was studied in 0.1 N HCl (pH 1.2), distilled water, and phosphate buffer (pH 7.4). The physical examination of the beads indicated the presence of drug crystals with no interaction between the drug and polymers. The drug release was dependent on the ionic properties of the polymers and the pH of the release media. In acidic pH, chitosan beads showed a rapid drug release, whereas a sustained drug release was obtained from Gelrite beads. In contrast, the drug release in phosphate buffer was rapid from Gelrite, and chitosan showed a sustained drug release. The results of drug release from Gelrite were comparable to that from alginate beads. Gelrite is recommended as an anionic polysaccharide for sustained-release preparations.
Collapse
Affiliation(s)
- E A el Fattah
- Department of Pharmaceutics, Mansoura University, Egypt
| | | | | | | |
Collapse
|
49
|
al-Helw AA, Al-Angary AA, Mahrous GM, al-Dardari MM. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone. J Microencapsul 1998; 15:373-82. [PMID: 9608399 DOI: 10.3109/02652049809006864] [Citation(s) in RCA: 46] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Chitosan microspheres containing phenobarbitone were successfully prepared by glutaraldehyde cross-linking of an aqueous acetic acid dispersion of chitosan in light liquid paraffin containing sorbitan mono-oleate as a stabilizing agent. Uniform and spherical microspheres, with a loading efficiency up to 57.2%, could be prepared depending on the preparation conditions. The main parameters affecting the preparation and the performance of the prepared microspheres were the molecular weight and concentration of chitosan as well as the concentration of the used stabilizing agent. The incorporation of citric acid into the microspheres was found to increase the formation of a water-soluble gel when the microspheres come in contact with the dissolution medium increasing the rate of drug release. The particle size was shifted towards smaller diameters with increased concentration of sorbitan mono-oleate, up to 4.0% v/v, by use of a lower concentration of chitosan (1.0% w/v) and chitosan with low molecular weight. Rapid initial drug release (20-30% of the incorporated drug) was exhibited in all the prepared microspheres followed by slow release of the remaining amount of the drug. The release rate of the drug from the microspheres prepared from high molecular weight chitosan was slow in comparison with that prepared from medium and low molecular weight chitosan. High concentrations of sorbitan mono-oleate increased the rate of drug release.
Collapse
Affiliation(s)
- A A al-Helw
- Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
| | | | | | | |
Collapse
|
50
|
Remuñán-López C, Lorenzo-Lamosa ML, Vila-Jato JL, Alonso MJ. Development of new chitosan-cellulose multicore microparticles for controlled drug delivery. Eur J Pharm Biopharm 1998; 45:49-56. [PMID: 9689535 DOI: 10.1016/s0939-6411(97)00122-7] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Chitosan (CS) is a very interesting biomaterial for drug delivery; however its use in oral administration is restricted by its fast dissolution in the stomach and limited capacity for controlling the release of drugs. To address this limitation, a new microparticulate CS controlled release system, consisting of hydrophilic CS microcores entrapped in a hydrophobic cellulosic polymer, such as cellulose acetate butyrate (CAB) or ethyl cellulose (EC) was proposed. These microparticles were obtained with different types of CS and various core/coat ratios, with the particle size in all cases being smaller that 70 microns. Using sodium diclofenac (SD) and fluorescein isothiocyanate-labeled bovine serum albumin (FITC-BSA) as model compounds, the properties of these new microparticles for the entrapment and controlled release of drugs and proteins were investigated. Results showed that the entrapment efficiency of SD was very high irrespective of the processing conditions. Furthermore, for both model compounds (SD and FITC-BSA) it was possible to modulate the in vitro release of the encapsulated molecules by changing the core properties (CS salt, Mw, core/coat ratio) or the coating polymer. The microparticles were stable at low pH and thus, suitable for oral delivery without requiring any harmful cross-linkage treatment.
Collapse
|